These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24996013)

  • 1. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
    Manna PP; Hira SK; Basu A; Bandyopadhyay S
    Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
    Manna PP; Chakrabarti G; Bandyopadhyay S
    Vaccine; 2010 Jan; 28(3):803-10. PubMed ID: 19879234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
    J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of membrane-associated TNF in the killing of Leishmania donovani parasites by macrophages.
    Lohmann-Matthes ML; Lüttig B; Hockertz S
    Behring Inst Mitt; 1991 Feb; (88):125-32. PubMed ID: 2049029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
    Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
    J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
    Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
    FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 function in apoptosis of T lymphocytes in canine visceral leishmaniasis.
    Chiku VM; Silva KL; de Almeida BF; Venturin GL; Leal AA; de Martini CC; de Rezende Eugênio F; Dos Santos PS; de Lima VM
    Immunobiology; 2016 Aug; 221(8):879-88. PubMed ID: 27016050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
    Basu R; Bhaumik S; Haldar AK; Naskar K; De T; Dana SK; Walden P; Roy S
    Infect Immun; 2007 Dec; 75(12):5956-66. PubMed ID: 17908806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
    Engwerda CR; Smelt SC; Kaye PM
    Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional heterogeneity of macrophage precursor cells from spleen of Leishmania donovani-infected and untreated mice.
    Hockertz S; Baccarini M; Lohmann-Matthes ML
    J Immunol; 1989 Apr; 142(7):2489-94. PubMed ID: 2926141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and effect of TNF-alpha in experimental visceral leishmaniasis.
    Tumang MC; Keogh C; Moldawer LL; Helfgott DC; Teitelbaum R; Hariprashad J; Murray HW
    J Immunol; 1994 Jul; 153(2):768-75. PubMed ID: 8021511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B; Sadick MD; Pearson RD
    J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
    Singh N; Sundar S
    PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.